Viewing StudyNCT05918809



Ignite Creation Date: 2024-05-06 @ 7:09 PM
Last Modification Date: 2024-10-26 @ 3:01 PM
Study NCT ID: NCT05918809
Status: COMPLETED
Last Update Posted: 2023-06-26
First Post: 2023-06-16

Brief Title: Real-world Resource Use and Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma DLBCL Inpatient and Outpatient Settings
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-07-25
Start Date Type: ACTUAL
Primary Completion Date: 2022-06-17
Primary Completion Date Type: ACTUAL
Completion Date: 2022-06-17
Completion Date Type: ACTUAL
First Submit Date: 2023-06-16
First Submit QC Date: June 16 2023
Study First Post Date: 2023-06-26
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-06-16
Last Update Post Date: 2023-06-26
Last Update Post Date Type: ACTUAL